Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Singular Genomics Systems, Inc. Transaction History

Mitsubishi Ufj Morgan Stanley Securities Co., Ltd.

$7.89 Million
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 12, 2021	SELL	$10.9 - $27.63 $37,496 - $95,047	-3,440 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$23.16 - $31.17 $79,670 - $107,224	3,440 New	3,440 $95,000

Others Institutions Holding OMIC

# of Institutions

Shares Held

1.43M

Call Options Held

Put Options Held

Revelation Capital Management, LLC Sausalito, CA

1.42M
Shares

$30.7 Million
83.16% of portfolio
Trustcore Financial Services, LLC

15.3K
Shares

$331,704
0.0% of portfolio

View Full List

About Singular Genomics Systems, Inc.

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.54B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

More about OMIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Morgan Stanley Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. with notifications on news.

Account